Thursday, November 21, 2024
Subscribe American Journal of Medicine Free Newsletter
CardiologyA Diagnosis at Hand: Pulmonary Arterial Hypertension

A Diagnosis at Hand: Pulmonary Arterial Hypertension

Hands

A classic physical examination finding pointed to underlying disease in a 43-year-old Hispanic woman. On presenting to the Emergency Department, she reported progressive shortness of breath, fatigue, and chest pressure. One month earlier, she could exercise without limitation. However, in the ensuing interval, she developed increasing dyspnea and constant, nonexertional, left-sided chest pressure. A review of systems was notable for dysphagia. The patient denied palpitations, orthopnea, paroxysmal nocturnal dyspnea, or edema. She had no significant past medical or family history and denied tobacco, alcohol, or illicit drug use. An undocumented immigrant from Mexico, she had limited access to health care.

Assessment

The patient had stable vital signs: temperature 36°C (96.8°F); heart rate 73 beats per minute; blood pressure 116/89 mm Hg; and respirations 17 breaths per minute. Her oxygen saturation was 95% on room air, and her jugular venous pressure was elevated to 10 cm above the sternal angle. Cardiac examination revealed a nondisplaced point of maximum impulse, left parasternal heave, regular rhythm, normal S1, widely split S2, intensified P2, and no murmurs. Her lungs were clear with no crackles or rales. She had 1+ bilateral pretibial edema and notable sclerodactyly of the fingers (Figure 1). Telangiectasias marked the patient’s cheeks and forehead (Figure 2).

Pertinent laboratory data were a peak troponin level of 0.08 ng/mL (ref <0.04 ng/mL) and a brain natriuretic peptide measurement of 702 pg/mL (ref <100 pg/mL). A chest radiograph disclosed cardiomegaly with a prominent right heart border and moderate vascular congestion but no pulmonary edema. Electrocardiogram findings were consistent with severe pulmonary hypertension (Figure 3). Chest computed tomography (CT) with contrast showed enlargement of the pulmonary artery, right atrium, and right ventricle, with no evidence of pulmonary embolism or interstitial lung disease.The patient’s constellation of signs and symptoms, coupled with results from the electrocardiogram and chest CT scan, indicated a diagnosis of pulmonary hypertension. Transthoracic echocardiography demonstrated a normal left ventricular ejection fraction (55%) with stage I diastolic dysfunction. Severe enlargement of the right atrium and right ventricle, marked reduction of right ventricular systolic function, and systolic septal flattening were consistent with right ventricular pressure overload. Moderate (2+) tricuspid regurgitation and an estimated right ventricular systolic pressure of 83 mm Hg were also noted (Figure 4).

Diagnosis

Despite the patient’s preliminary diagnosis of pulmonary hypertension, the etiology remained uncertain. The World Health Organization (WHO) classifies patients with pulmonary hypertension by etiology as follows: pulmonary arterial hypertension (Group 1), pulmonary hypertension secondary to left heart disease (Group 2), chronic lung disease or hypoxia, or both (Group 3), chronic thromboembolic disease (Group 4), and unclear or multifactorial etiology (Group 5).1

Right heart catheterization confirmed the diagnosis of severe pulmonary hypertension, measuring pulmonary artery pressure at 114/37 mm Hg (mean, 64 mm Hg), pulmonary capillary wedge pressure at 1 mm Hg, and right atrial mean pressure at 6 mm Hg. The cardiac index was 2.58 L/min/m2, and pulmonary vascular resistance was markedly elevated at 17.4 Wood units. Coronary angiography showed no evidence of obstructive coronary artery disease. Cardiac magnetic resonance imaging verified reduced right ventricular systolic function with an estimated ejection fraction of 20% (reference, 40%). A ventilation-perfusion scan was negative for any mismatch.

To read this article in its entirety please visit our website.

-Kavita Khaira, MD, Roblee Allen, MD, Ezra A. Amsterdam, MD

This article originally appeared in the August 2016 issue of The American Journal of Medicine.

Latest Posts

lupus

Sarcoidosis with Lupus Pernio in an Afro-Caribbean Man

A 54-year-old man of Afro-Caribbean ancestry presented with a 2-month history of nonproductive cough, 10-day history of constant subjective fevers, and a 1-day history...
Flue Vaccine

Flu Vaccination to Prevent Cardiovascular Mortality (video)

0
"Influenza can cause a significant burden on patients with coronary artery disease," write Barbetta et al in The American Journal of Medicine. For this...
varicella zoster

Varicella Zoster Virus-Induced Complete Heart Block

0
Complete heart block is usually caused by chronic myocardial ischemia and fibrosis but can also be induced by bacterial and viral infections. The varicella...
Racial justice in healthcare

Teaching Anti-Racism in the Clinical Environment

0
"Teaching Anti-Racism in the Clinical Environment: The Five-Minute Moment for Racial Justice in Healthcare" was originally published in the April 2023 issue of The...
Invisible hand of the market

The ‘Invisible Hand’ Doesn’t Work for Prescription Drugs

0
Pharmaceutical innovation has been responsible for many “miracles of modern medicine.” Reliance on the “invisible hand” of Adam Smith to allocate resources in the...
Joseph S. Alpert, MD

New Coronary Heart Disease Risk Factors

0
"New Coronary Heart Disease Risk Factors" by AJM Editor-in Chief Joseph S. Alpert, MD was originally published in the April 2023 issue of The...
Cardiovascular risk from noncardiac activities

Cardiac Risk Related to Noncardiac & Nonsurgical Activities

0
"Assessment of Cardiovascular Risk for Noncardiac and Nonsurgical Activities" was originally published in the April 2023 issue of The American Journal of Medicine. Cardiovascular risk...